Barclays Maintains Overweight on Visteon, Lowers Price Target to $125

Benzinga Newsdesk www.benzinga.com Negative 83.3%

Neg 83.3% Neu 0% Pos 0%

Barclays analyst Dan Levy maintains Visteon (NASDAQ:VC) with a Overweight and lowers the price target from $145 to $125.